Technology insight: can neuroimaging provide insights into the role of ischemia in Baló's concentric sclerosis?

Nature Clinical Practice Neurology

Volumn 3, Issue 6, 2007, Pages 341-348

  Mowry, Ellen M ^a   Woo, John H ^a   Ances, Beau M ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; HEAT SHOCK PROTEIN 70; HYPOXIA INDUCIBLE FACTOR 1ALPHA; N ACETYLASPARTIC ACID;

AUTOPSY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CELL LOSS; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DEMYELINATING DISEASE; DEMYELINATION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISEASE MARKER; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; LONGITUDINAL STUDY; MULTIPLE SCLEROSIS; MYELINATED NERVE; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PATIENT CARE; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; REVIEW; TECHNOLOGY;

DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; DIFFUSE CEREBRAL SCLEROSIS OF SCHILDER; HUMANS; ISCHEMIC PRECONDITIONING; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 34250216037     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0519     Document Type: Review

References (55)

1. Karaarslan E et al. (2001) Baló's concentric sclerosis: clinical and radiologic features of five cases. AJNR Am J Neuroradiol 22: 1362-1367
2. Anschel DJ (2006) Reply to the paper by Wiendl et al.: Diffusion abnormality in Baló's concentric sclerosis: Clues for the pathogenesis. Eur Neurol 55: 111-112
3. Mowry EM et al. (2007) Baló's concentric sclerosis presenting as a stroke-like syndrome. Nat Clin Pract Neurol 3: 349-354
4. Brinar VV (2004) Non-MS recurrent demyelinating diseases. Clin Neurol Neurosurg 106: 197-210
5. Brinar VV and Poser CM (2006) The spectrum of disseminated encephalomyelitis. Clin Neurol Neurosurg 108: 295-310
6. Poser CM and Brinar VV (2004) The nature of multiple sclerosis. Clin Neurol Neurosurg 106: 159-171
7. Yao DL et al. (1994) Concentric sclerosis (Baló): Morphometric and in situ hybridization study of lesions in six patients. Ann Neurol 35: 18-30
8. Moore GR et al. (1985) Baló's concentric sclerosis: New observations on lesion development. Ann Neurol 17: 604-611
9. Chen CJ et al. (1999) Serial magnetic resonance imaging in patients with Baló's concentric sclerosis: Natural history of lesion development. Ann Neurol 46: 651-656
10. Moore GR et al. (2001) Baló's concentric sclerosis: Surviving normal myelin in a patient with a relapsing-remitting clinical course. Mult Scler 7: 375-382
11. Khonsari RH and Calvez V (2007) The origins of concentric demyelination: self-organization in the human brain. PloS ONE 2: E150
12. Stadelmann C et al. (2005) Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis. Brain 128: 979-987
13. Sekijima Y et al. (1997) Serial magnetic resonance imaging (MRI) study of a patient with Baló's concentric sclerosis treated with immunoadsorption plasmapheresis. Mult Scler 2: 291-294
14. Chen CJ (2001) Serial proton magnetic resonance spectroscopy in lesions of Baló concentric sclerosis. J Comput Assist Tomogr 25: 713-718
15. Gu J et al. (2003) Concentric sclerosis: Imaging diagnosis and clinical analysis of 3 cases. Neurol India 51: 528-530
16. Chen CJ et al. (1996) Serial MRI studies in pathologically verified Baló's concentric sclerosis. J Comput Assist Tomogr 20: 732-735
17. Kim MO et al. (1997) Baló's concentric sclerosis: A clinical case study of brain MRI, biopsy, and proton magnetic resonance spectroscopic findings. J Neurol Neurosurg Psychiatry 62: 655-658
18. Murakami Y et al. (1998) Baló's concentric sclerosis in a 4-year-old Japanese infant. Brain Dev 20: 250-252
19. Singh S et al. (1999) Baló's concentric sclerosis: Value of magnetic resonance imaging in diagnosis. Australas Radiol 43: 400-404
20. Pohl D et al. (2005) Baló's concentric sclerosis associated with primary human herpesvirus 6 infection. J Neurol Neurosurg Psychiatry 76: 1723-1725
21. Wiendl H et al. (2005) Diffusion abnormality in Baló's concentric sclerosis: Clues for the pathogenesis. Eur Neurol 53: 42-44
22. Tersegno MM and Reich DR (1993) Baló's concentric sclerosis: A rare form of multiple sclerosis manifested as a dominant cerebral mass without other white matter lesions on MR. AJR Am J Roentgenol 160: 901
23. Chen CJ et al. (1996) Baló's concentric sclerosis: MRI. Neuroradiology 38: 322-324
24. Gharagozloo AM et al. (1994) Antemortem diagnosis of Baló concentric sclerosis: Correlative MR imaging and pathologic features. Radiology 191: 817-819
25. Ng SH et al. (1999) MRI features of Baló's concentric sclerosis. Br J Radiol 72: 400-403
26. Caracciolo JT et al. (2001) Pathognomonic MR imaging findings in Baló concentric sclerosis. AJNR Am J Neuroradiol 22: 292-293
27. Kastrup O et al. (2002) Baló's concentric sclerosis: Evolution of active demyelination demonstrated by serial contrast-enhanced MRI. J Neurol 249: 811-814
28. Nagi S et al. (2005) Baló's concentric sclerosis in a North-African patient [French]. Rev Neurol (Paris) 161: 78-80
29. Spiegel M et al. (1989) MRI study of Baló's concentric sclerosis before and after immunosuppressive therapy. J Neurol 236: 487-488
30. Iannucci G et al. (2000) Vanishing Baló-like lesions in multiple sclerosis. J Neurol Neurosurg Psychiatry 69: 399-400
31. Louboutin JP and Elie B (1995) Treatment of Baló's concentric sclerosis with immunosuppressive drugs followed by multimodality evoked potentials and MRI. Muscle Nerve 18: 1478-1480
32. Weber R et al. (2006) Present status of magnetic resonance imaging and spectroscopy in animal stroke models. J Cereb Blood Flow Metab 26: 591-604
33. Kuker W et al. (2004) Modern MRI tools for the characterization of acute demyelinating lesions: Value of chemical shift and diffusion-weighted imaging. Neuroradiology 46: 421-426
34. Petzold GC et al. (2005) Diffusion-weighted magnetic resonance imaging of acute disseminated encephalomyelitis. Eur J Neurol 12: 735-736
35. Rosso C et al. (2006) Diffusion-weighted MR imaging characteristics of an acute stroke-like form of multiple sclerosis. AJNR Am J Neuroradiol 27: 1006-1008
36. Axer H et al. (2005) Initial DWI and ADC imaging may predict outcome in acute disseminated encephalomyelitis: Report of two cases of brain stem encephalitis. J Neurol Neurosurg Psychiatry 76: 996-998
37. Balasubramanya KS et al. (2007) Diffusion-weighted imaging and proton MR spectroscopy in the characterization of acute disseminated encephalomyelitis. Neuroradiology 49: 177-183
38. Bernarding J et al. (2002) Diffusion- and perfusion-weighted MR imaging in a patient with acute disseminated encephalomyelitis (ADEM). J Magn Reson Imaging 15: 96-100
39. Wuerfel J et al. (2004) Changes in cerebral perfusion precede plaque formation in multiple sclerosis: A longitudinal perfusion MRI study. Brain 127: 111-119
40. Phuttharak W et al. (2006) ADC measurements in various patterns of MS lesions. J Med Assoc Thai 89: 196-204
41. Kavanagh EG et al. (2006) Diffusion-weighted imaging findings in Baló concentric sclerosis. Br J Radiol 79: E28-e31
42. Pendlebury ST et al. (2000) Correlating magnetic resonance imaging markers of axonal injury and demyelination in motor impairment secondary to stroke and multiple sclerosis. Magn Reson Imaging 18: 369-378
43. Narayana PA (2005) Magnetic resonance spectroscopy in the monitoring of multiple sclerosis. J Neuroimaging 15 (Suppl): S46-S57
44. Bizzi A et al. (2001) Quantitative proton MR spectroscopic imaging in acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 22: 1125-1130
45. Mader I et al. (2005) MRI and proton MR spectroscopy in acute disseminated encephalomyelitis. Childs Nerv Syst 21: 566-572
46. Bruneteau G et al. (2005) Contribution of proton magnetic resonance spectroscopy to the diagnosis of Baló's concentric sclerosis [French]. Rev Neurol (Paris) 161: 455-458
47. Graham GD et al. (2001) Spectroscopic assessment of alterations in macromolecule and small-molecule metabolites in human brain after stroke. Stroke 32: 2797-2802
48. Lassmann H et al. (2001) Heterogeneity of multiple sclerosis pathogenesis: Implications for diagnosis and therapy. Trends Mol Med 7: 115-121
49. Kornek B and Lassmann H (2003) Neuropathology of multiple sclerosis - new concepts. Brain Res Bull 61: 321-326
50. Lucchinetti C et al. (2000) Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 47: 707-717
51. Aboul-Enein F et al. (2003) Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neurapathol Exp Neurol 62: 25-33
52. Lassmann H et al. (2003) A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions. Brain 126: 1347-1357
53. Aires L et al. (2005) Successful pregnancy of a patient with Baló's concentric sclerosis. Mult Scler 11: 346-348
54. Wakefield AJ et al. (1994) Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 47: 129-133
55. Dutta R et al. (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59: 478-489